ARCHIVES

Group Chairmen Object To “Directive” Language In Proposed Intergroup Study Guidelines

This article is from The Cancer Letter archive.

Vol. 10 No. 02 | January 13, 1984

Download PDF Visit The Full Archive

Related Articles

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

NCI-DOD Agreement Could Be Model For Similar Project With HCFA, Lee Says

March 8, 1996

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

PBS Runs Misleading Lung Screening Claim; Reporter and Subject on Mount Sinai Faculty

October 11, 2013

In Brief: Melanoma Precursors Consensus Conference Planned, DRCC Board Raps Centers Budget Cut

May 20, 1983